Intrinsic Value

Iovance Biotherapeutics, Inc. (IOVA)


+2.88 (+31.48%)

Enterprise Value -
Net Debt -147.28
Equity Value -
Shares Outstanding 159.26
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt